Topics

Phase I/II Studies of Annamycin in Acute Myeloid Leukemia Report Positive Interim Results

19:00 EST 3 Dec 2019 | Cancer Networks

Additional positive interim safety and efficacy data were reported for annamycin in the treatment of patients with relapsed or refractory acute myeloid leukemia.

Original Article: Phase I/II Studies of Annamycin in Acute Myeloid Leukemia Report Positive Interim Results

NEXT ARTICLE

More From BioPortfolio on "Phase I/II Studies of Annamycin in Acute Myeloid Leukemia Report Positive Interim Results"

Quick Search

Relevant Topic

Leukemia
Leukemia is a type of cancer of the blood or bone marrow characterized by an abnormal increase of immature white blood cells called "blasts". Leukemia is a broad term covering a spectrum of diseases. In turn, it is part of the even broader grou...